PUBLISHER: Allied Market Research | PRODUCT CODE: 1193142
PUBLISHER: Allied Market Research | PRODUCT CODE: 1193142
The global electrolarynx market was valued at $409.5 million in 2021 and is projected to reach $703.0 million by 2031, registering a CAGR of 5.5% from 2022 to 2031. An electronic larynx (electrolarynx) is battery-powered equipment that generates sound so that a person can speak. There are various makes and models, but they are typically the size of a small electric razor. When a person wants to talk, this little, battery-operated gadget is put right on the neck, beneath the chin. The electrolarynx produces a vibration that is sent via the skin to the throat when a person presses a button on the device. With the mouth, tongue, lips, and teeth, the patient forms this sound into words.
The artificial larynx device allows individuals who have lost their voice to adjust and save several sound frequency parameters to produce improved speech. Voice restoration devices are most utilized after a laryngectomy, in which the whole voice box, known as the larynx, is permanently removed, separating the windpipe and food pipe.
The key factors that drive the growth of the market are the rise in the prevalence of laryngeal cancer and the surge in the consumption of alcohol and tobacco are the major factors drive the electrolarynx market. For instance, according to the report published by the American Cancer Society, it has been estimated for laryngeal cancer in the U.S. for 2022 that, about 12,470 new cases of laryngeal cancer (9,820 in men and 2,650 in women) were recorded in about 3,820 people (3,070 men and 750 women) died from laryngeal cancer. Furthermore, the increase in the cases of respiratory papilloma which is caused by the human papillomavirus (HPV) is usually benign (non-cancerous). These growths can lead to vocal cord damage and airway problems, which increases the demand for electrolarynx devices hence propelling the growth of the market. Moreover, the high adoption of these medical devices and continuously investing in R&D by numerous key players for the launch of innovative and technologically advanced electrolarynx devices are anticipated to fuel the market growth.
However, the high cost of electrolarynx devices hampers market growth. Conversely, rising cases of hypopharyngeal cancer, the emerging healthcare market in developing countries, and low-income countries lacking access to basic healthcare, and an increase in the risk of laryngeal cancer are expected to provide a lucrative opportunity for the growth of the market during the forecast period.
The electrolarynx market is segmented on the basis of type, application, end-user, and region. By type, the market is segmented into external batteries and built-in batteries. By application, it is bifurcated into laryngeal cancer and speech rehabilitation. By end user, the market is segmented into hospitals, ambulatory surgical centers, and others. Region-wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
North America accounted for a majority of the electrolarynx market share in 2021 and is anticipated to remain dominant during the forecast period. The electrolarynx market is mainly driven by the presence of well-established healthcare facilities and a high prevalence rate of laryngeal cancer. Moreover, an increase in the number of people consuming alcohol and tobacco and a rise in the demand for electrolarynx devices are contributing to the market growth in the region. Furthermore, an increasing number of key players in this region are involved in R&D activities for the development of technologically advanced medical devices, and the initiatives being undertaken by various organizations to spread awareness and reduce the prevalence rate of hypopharyngeal cancer through innovative research are expected to fuel the market growth.
Asia-Pacific is expected to register the fastest CAGR during the forecast period. This is due to the presence of high unmet medical needs and constantly improving healthcare infrastructure. In addition, the rapidly growing population, various lifestyle changes such as the high rate of people consuming alcohol and tobacco, rising incidence of laryngeal cancer, improvement in the quality of diagnosis, and increasing patient affordability are set to drive the market in the Asia-Pacific region. This helps several market players to invest in Asia-Pacific countries, which in turn will further contribute to the growth of the market.
The key players that operate in the electrolarynx market are Atos Medical, Amplicord, Fountain Head Marketing, Inc., Medline Industries, Nu Vois, Labaex, InHealth Technologies, Romet, Servona GmbH, Luminaud, and Ultravoice.
Key Benefits For Stakeholders
By Type
By Application
By End user
By Region